Sysmex Makes Top Quality Haematology Available For All at EuroMedLab, Paris

NORDERSTEDT, Germany, June 22, 2015 /PRNewswire/ --

The Sysmex Corporation, the global leader in haematology, unveiled its latest series of haematology analysers at the annual IFCC congress, EuroMedLab JIB in Paris today. The XN-L series follows in the footsteps of its game-changing big brother, the XN-Series. The new, smaller XN-L Series makes top quality haematology available for all. Sysmex is yet again changing the perspective in the field of haematology.  

When introduced in 2011, the XN-Series set new standards in haematology. Yet not every lab needs the scope and detail provided by the Sysmex flagship. The XN-L meets the demands of smaller scale labs and those needing a top quality backup solution. Labs with perhaps a smaller budget or less detailed needs can now offer their clients the top standards for which Sysmex is world famous. Both the XN and XN-L are on show at this year's EuroMedLab in Paris.

Sysmex is also showing solutions in its other areas of expertise, including urinalysis, Point of Care and morphology. Thanks to its exclusive distribution rights, it has another game changer on show - the ultra-flexible intelligent lab automation provided by GLP systems. Another highlight is the introduction of a new solution in haemostasis, the CA-1600 with increased results security thanks to pre-analytical checks and incorporating coagulation, chromogenic and immunoassay methodologies.  

Closely related to its core technology, Sysmex purchased flow cytometry pioneers Sysmex Partec in 2013. Known especially in resource-poor settings for its essential healthcare and HIV/AIDS, TB and malaria monitoring solutions, visitors to EuroMedLab can witness the developments over the last 18 months and the great promise the acquisition holds for the future.

Sysmex can be found at booth G23 from 21-25 June.

About Sysmex    

Sysmex Corporation is a world leader in clinical laboratory systemization and solutions, including laboratory diagnostics, laboratory automation and clinical information systems. Serving customers for more than 40 years, Sysmex focuses on technological leadership in diagnostic science and information tools that make a difference in the health of people worldwide. The company is also exploring emerging opportunities in the life science field. Its R&D efforts focus on the development of high-value-added testing and diagnostic technologies that are innovative, original and optimize individual health. Sysmex also seeks to leverage its state-of-the-art technologies for gene and protein analysis. The company, headquartered in Kobe, Japan, has subsidiaries in North America, Latin America, Europe, China and Asia Pacific and employs more than 6,000 employees worldwide. Sysmex Corporation is listed in the top tier of the Tokyo Stock Exchange. For more information about Sysmex Corporation and its affiliate companies, please visit http://www.sysmex.co.jp/en. For information about Sysmex Europe, please visit http://www.sysmex-europe.com.  

For more details, please contact: Mrs Rikke Rytter, [email protected]

SOURCE Sysmex Europe GmbH